Together we will beat cancer

Donate

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

Read More

Targeted drug improves survival for children with non-Hodgkin lymphoma

New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.

Read More

Engineered cell therapy given initial ‘no’ for aggressive adult lymphoma on NHS in England

A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England.

Read More